NDC 47781-419
buprenorphine transdermal system
Buprenorphine
buprenorphine transdermal system is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Alvogen Inc.. The primary component is Buprenorphine.
| Product ID | 47781-419_d6f7d51f-5b73-5235-efc8-3e388d02b5d9 |
| NDC | 47781-419 |
| Product Type | Human Prescription Drug |
| Proprietary Name | buprenorphine transdermal system |
| Generic Name | Buprenorphine |
| Dosage Form | Patch, Extended Release |
| Route of Administration | TRANSDERMAL |
| Marketing Start Date | 2022-05-17 |
| Marketing Category | ANDA / |
| Application Number | ANDA207490 |
| Labeler Name | Alvogen Inc. |
| Substance Name | BUPRENORPHINE |
| Active Ingredient Strength | 15 ug/h |
| Pharm Classes | Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA] |
| DEA Schedule | CIII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |